Recruiting Duchenne Muscular Dystrophy Studies in Stanford
About Duchenne Muscular Dystrophy Clinical Trials in Stanford
Duchenne muscular dystrophy is a severe genetic disorder characterized by progressive muscle degeneration and weakness, primarily affecting boys. It is caused by mutations in the dystrophin gene. Treatment includes corticosteroids, gene therapies, and supportive care to maintain mobility and function.
There are currently 1 duchenne muscular dystrophy clinical trials recruiting participants in Stanford, CA. These studies are seeking a combined 44 participants. Research is being sponsored by Nationwide Children's Hospital. Clinical trial participation is free and participants receive study-related medical care at no cost.
Duchenne Muscular Dystrophy Clinical Trials in Stanford — FAQ
Are there duchenne muscular dystrophy clinical trials in Stanford?
Yes, there are 1 duchenne muscular dystrophy clinical trials currently recruiting in Stanford, CA. Browse the studies on this page to find one that fits.
How do I join a clinical trial in Stanford?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Stanford research site will contact you about next steps.
Are clinical trials in Stanford free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Stanford studies also compensate for your time and travel.
What duchenne muscular dystrophy treatments are being tested?
The 1 active trials in Stanford are testing new therapies including novel drugs, biologics, and treatment approaches for duchenne muscular dystrophy.
Data updated July 13, 2026 from ClinicalTrials.gov